|
Market Closed -
London S.E.
02:30:00 2025-05-01 EDT
|
5-day change | 1st Jan Change | ||
| 0.2250 GBX | -.--% |
|
+2.27% | - |
| 03-01 | Kanabo Group PLC Announces Termination Of Director Appointment of Sharon Malka, Effective February 27, 2026 | CI |
| 12-12 | Quantum Helium increases Sagebrush project interest | AN |
| Market Cap | 5.38M 7.18M 6.44M 5.89M 10.13M 675M 10.45M 70.98M 28.3M 360M 26.97M 26.39M 1.14B | P/E 2022 |
-1.15x | P/E 2023 | -1.88x |
|---|---|---|---|---|---|
| Enterprise Value | 2.44M 3.26M 2.92M 2.67M 4.59M 306M 4.74M 32.19M 12.83M 163M 12.23M 11.97M 516M | EV / Sales 2022 |
8.33x | EV / Sales 2023 | 16.5x |
| Free-Float |
96.57% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 week | +2.27% | ||
| Current month | +2.27% | ||
| 1 month | +2.27% | ||
| 3 months | +2.27% |
| Current year | 0.22 |  | 0.22 |
| 1 year | 0.22 | | 0.22 |
| 3 years | 0.15 | | 3.2 |
| 5 years | 0.15 | | 16.5 |
| 10 years | 0.15 | | 51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Avihu Tamir
CEO | Chief Executive Officer | 45 | 2021-06-27 |
Ophir Shimshi
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Avihu Tamir
BRD | Director/Board Member | 45 | 2021-06-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/31/24 | Others | Chairman | 18,011,111 | 2.8479% | ||
| 10/29/24 | Free | Chairman | 17,361,111 | 2.7452% | ||
| 8/28/24 | Buy | Chief Technology Officer | 75,187 | 0.0119% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +2.27% | -.--% | -83.93% | 1.86M | |
| -0.79% | -4.48% | +46.48% | +125.69% | 1,206B | |
| +1.43% | +1.11% | +48.05% | +83.05% | 665B | |
| +1.07% | -1.21% | +32.92% | +104.92% | 515B | |
| -0.36% | -3.25% | +45.42% | +65.10% | 381B | |
| -0.14% | -1.87% | +70.06% | +41.09% | 362B | |
| -0.78% | -0.52% | +30.47% | +58.09% | 307B | |
| -0.80% | -0.21% | +7.98% | +36.17% | 289B | |
| +0.03% | -1.20% | +43.79% | +69.83% | 249B | |
| -0.41% | -2.22% | +40.43% | +107.03% | 207B | |
| Average | -0.08% | -2.39% | +36.56% | +60.70% | 417.97B | |
| Weighted average by Cap. | -0.04% | -1.96% | +42.71% | +88.11% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 603K 806K 723K 661K 1.14M 75.75M 1.17M 7.96M 3.17M 40.42M 3.02M 2.96M 128M | 895K 1.2M 1.07M 980K 1.69M 112M 1.74M 11.82M 4.71M 59.99M 4.49M 4.39M 189M |
| Net income | -6.87M -9.18M -8.23M -7.52M -12.94M -863M -13.35M -90.67M -36.16M -460M -34.45M -33.71M -1.45B | -7.99M -10.67M -9.57M -8.75M -15.05M -1B -15.52M -105M -42.05M -535M -40.07M -39.21M -1.69B |
| Net Debt | -3.01M -4.03M -3.61M -3.3M -5.67M -378M -5.85M -39.77M -15.86M -202M -15.11M -14.79M -637M | -2.94M -3.93M -3.52M -3.22M -5.54M -369M -5.71M -38.79M -15.47M -197M -14.74M -14.42M -622M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- KNB Stock
Select your edition
All financial news and data tailored to specific country editions
